Literature DB >> 23640492

Phenotypic polarization of macrophages in atherosclerosis.

Norbert Leitinger1, Ira G Schulman.   

Abstract

Macrophages orchestrate the inflammatory response in inflamed tissues, and recent work indicates that these cells can alter their phenotypes and functions accordingly in response to changes in the microenvironment. Initial work in models of cardiovascular disease used immunologic markers to characterize macrophage phenotypes present in atherosclerotic plaque, and these studies have lately been extended through the use of markers that are more specific for atherosclerosis and metabolic disease. Together, these studies have led to a novel view of the function of macrophages in the development of atherosclerosis that suggests dynamic plasticity. Understanding this plasticity and the ensuing macrophage heterogeneity could lead to novel strategies of pharmacological intervention to combat chronic inflammation in metabolic diseases. Most importantly, revealing the functional characteristics of individual macrophage phenotypes will lead to a better understanding of their contribution to lesion development and plaque stability.

Entities:  

Keywords:  atherosclerosis; chemokines; cytokines; macrophages

Mesh:

Year:  2013        PMID: 23640492      PMCID: PMC3745999          DOI: 10.1161/ATVBAHA.112.300173

Source DB:  PubMed          Journal:  Arterioscler Thromb Vasc Biol        ISSN: 1079-5642            Impact factor:   8.311


  72 in total

1.  PPARgamma activation primes human monocytes into alternative M2 macrophages with anti-inflammatory properties.

Authors:  M Amine Bouhlel; Bruno Derudas; Elena Rigamonti; Rébecca Dièvart; John Brozek; Stéphan Haulon; Christophe Zawadzki; Brigitte Jude; Gérard Torpier; Nikolaus Marx; Bart Staels; Giulia Chinetti-Gbaguidi
Journal:  Cell Metab       Date:  2007-08       Impact factor: 27.287

2.  Distribution of macrophage polarization markers in human atherosclerosis.

Authors:  J Lauran Stöger; Marion J J Gijbels; Saskia van der Velden; Marco Manca; Chris M van der Loos; Erik A L Biessen; Mat J A P Daemen; Esther Lutgens; Menno P J de Winther
Journal:  Atherosclerosis       Date:  2012-09-26       Impact factor: 5.162

3.  Non-redundant roles for LXRalpha and LXRbeta in atherosclerosis susceptibility in low density lipoprotein receptor knockout mice.

Authors:  Eric D Bischoff; Chris L Daige; Mary Petrowski; Harry Dedman; Jennifer Pattison; Joseph Juliano; Andrew C Li; Ira G Schulman
Journal:  J Lipid Res       Date:  2010-05       Impact factor: 5.922

4.  ABCA1 protein enhances Toll-like receptor 4 (TLR4)-stimulated interleukin-10 (IL-10) secretion through protein kinase A (PKA) activation.

Authors:  Loretta Ma; Fumin Dong; Maryam Zaid; Ashok Kumar; Xiaohui Zha
Journal:  J Biol Chem       Date:  2012-10-10       Impact factor: 5.157

5.  Regulation of absorption and ABC1-mediated efflux of cholesterol by RXR heterodimers.

Authors:  J J Repa; S D Turley; J A Lobaccaro; J Medina; L Li; K Lustig; B Shan; R A Heyman; J M Dietschy; D J Mangelsdorf
Journal:  Science       Date:  2000-09-01       Impact factor: 47.728

6.  Defective phagocytosis of apoptotic cells by macrophages in atherosclerotic lesions of ob/ob mice and reversal by a fish oil diet.

Authors:  Suzhao Li; Yu Sun; Chien-Ping Liang; Edward B Thorp; Seongah Han; Andreas W Jehle; Viswanathan Saraswathi; Brian Pridgen; Jenny E Kanter; Rong Li; Carrie L Welch; Alyssa H Hasty; Karin E Bornfeldt; Jan L Breslow; Ira Tabas; Alan R Tall
Journal:  Circ Res       Date:  2009-10-15       Impact factor: 17.367

7.  Nuclear receptor ERR alpha and coactivator PGC-1 beta are effectors of IFN-gamma-induced host defense.

Authors:  Junichiro Sonoda; Josée Laganière; Isaac R Mehl; Grant D Barish; Ling-Wa Chong; Xiangli Li; Immo E Scheffler; Dennis C Mock; Alain R Bataille; Francois Robert; Chih-Hao Lee; Vincent Giguère; Ronald M Evans
Journal:  Genes Dev       Date:  2007-08-01       Impact factor: 11.361

8.  Macrophage Phenotype Modulation by CXCL4 in Atherosclerosis.

Authors:  Christian A Gleissner
Journal:  Front Physiol       Date:  2012-01-13       Impact factor: 4.566

9.  Liver LXRα expression is crucial for whole body cholesterol homeostasis and reverse cholesterol transport in mice.

Authors:  Yuan Zhang; Sarah R Breevoort; Jerry Angdisen; Mingui Fu; Daniel R Schmidt; Sam R Holmstrom; Steven A Kliewer; David J Mangelsdorf; Ira G Schulman
Journal:  J Clin Invest       Date:  2012-04-09       Impact factor: 14.808

10.  Bone marrow NR4A expression is not a dominant factor in the development of atherosclerosis or macrophage polarization in mice.

Authors:  Lily C Chao; Erin Soto; Cynthia Hong; Ayaka Ito; Liming Pei; Ajay Chawla; Orla M Conneely; Rajendra K Tangirala; Ronald M Evans; Peter Tontonoz
Journal:  J Lipid Res       Date:  2013-01-03       Impact factor: 5.922

View more
  98 in total

Review 1.  Lifestyle effects on hematopoiesis and atherosclerosis.

Authors:  Matthias Nahrendorf; Filip K Swirski
Journal:  Circ Res       Date:  2015-02-27       Impact factor: 17.367

Review 2.  Modifiable Cardiovascular Risk, Hematopoiesis, and Innate Immunity.

Authors:  Maximilian J Schloss; Filip K Swirski; Matthias Nahrendorf
Journal:  Circ Res       Date:  2020-04-23       Impact factor: 17.367

3.  Deletion of Macrophage Low-Density Lipoprotein Receptor-Related Protein 1 (LRP1) Accelerates Atherosclerosis Regression and Increases C-C Chemokine Receptor Type 7 (CCR7) Expression in Plaque Macrophages.

Authors:  Paul A Mueller; Lin Zhu; Hagai Tavori; Katherine Huynh; Ilaria Giunzioni; John M Stafford; MacRae F Linton; Sergio Fazio
Journal:  Circulation       Date:  2018-10-23       Impact factor: 29.690

4.  Early intermittent hypoxia induces proatherogenic changes in aortic wall macrophages in a murine model of obstructive sleep apnea.

Authors:  Alex Gileles-Hillel; Isaac Almendros; Abdelnaby Khalyfa; Shelley X Zhang; Yang Wang; David Gozal
Journal:  Am J Respir Crit Care Med       Date:  2014-10-15       Impact factor: 21.405

5.  Murine Norovirus Infection Variably Alters Atherosclerosis in Mice Lacking Apolipoprotein E.

Authors:  Charlie C Hsu; Jisun Paik; Thea L Brabb; Kevin D O'Brien; Jinkyu Kim; Brittany G Sullivan; Kelly L Hudkins; Audrey Seamons; Jennifer C Finley; Stacey M Meeker; Lillian Maggio-Price
Journal:  Comp Med       Date:  2015-10       Impact factor: 0.982

6.  Equivocal usefulness of FDG for the noninvasive imaging of abdominal aortic aneurysms.

Authors:  Laurent M Riou; Gérald Vanzetto; Alexis Broisat; Daniel Fagret; Catherine Ghezzi
Journal:  Eur J Nucl Med Mol Imaging       Date:  2014-12       Impact factor: 9.236

7.  Regulation of monocyte/macrophage polarisation by extracellular RNA.

Authors:  Hector A Cabrera-Fuentes; Mercedes L Lopez; Sara McCurdy; Silvia Fischer; Svenja Meiler; Yvonne Baumer; Sebastian P Galuska; Klaus T Preissner; William A Boisvert
Journal:  Thromb Haemost       Date:  2015-01-15       Impact factor: 5.249

8.  Vitamin D Protects Against Atherosclerosis via Regulation of Cholesterol Efflux and Macrophage Polarization in Hypercholesterolemic Swine.

Authors:  Kai Yin; Yong You; Vicki Swier; Lin Tang; Mohamed M Radwan; Amit N Pandya; Devendra K Agrawal
Journal:  Arterioscler Thromb Vasc Biol       Date:  2015-09-17       Impact factor: 8.311

9.  Vascular smooth muscle cell-derived transforming growth factor-β promotes maturation of activated, neointima lesion-like macrophages.

Authors:  Allison Ostriker; Henrick N Horita; Joanna Poczobutt; Mary C M Weiser-Evans; Raphael A Nemenoff
Journal:  Arterioscler Thromb Vasc Biol       Date:  2014-02-13       Impact factor: 8.311

10.  Macrophage inflammatory markers are associated with subclinical carotid artery disease in women with human immunodeficiency virus or hepatitis C virus infection.

Authors:  Iftach Shaked; David B Hanna; Christian Gleißner; Brenda Marsh; Jill Plants; Daniel Tracy; Kathryn Anastos; Mardge Cohen; Elizabeth T Golub; Roksana Karim; Jason Lazar; Vinayaka Prasad; Phyllis C Tien; Mary A Young; Alan L Landay; Robert C Kaplan; Klaus Ley
Journal:  Arterioscler Thromb Vasc Biol       Date:  2014-03-20       Impact factor: 8.311

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.